Life Healthcare Group HoldingsJSE:LHC +1.16%56 EBITDA Margin % is 15.87% as of Mar. 2026, which is 13% below its 10-year median of 18.33. GuruFocus rates JSE:LHC with a GF Score™ of 56/100 and a GF Value™ of R15.61 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Life Healthcare Group Holdings ranks better than 62.87% on this metric.
Life Healthcare Group Holdings (JSE:LHC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Life Healthcare Group Holdings EBITDA Margin % Related Terms
Life Healthcare Group Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Life Healthcare Group Holdings EBITDA Margin % Chart
JSE:LHC vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Life Healthcare Group Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Life Healthcare Group Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Life Healthcare Group Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Life Healthcare Group Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Life Healthcare Group Holdings (JSE:LHC) has a EBITDA Margin % of 15.87% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Life Healthcare Group Holdings and its competitors. This is 13% below median its historical median of 18.33. Over the past decade, Life Healthcare Group Holdings' EBITDA Margin % has ranged from 4.13 to 24.44. According to the industry distribution chart, Life Healthcare Group Holdings ranks #248 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 37.1%.
Is Life Healthcare Group Holdings' EBITDA Margin % too high?
Life Healthcare Group Holdings' current EBITDA Margin % of 15.87% is 13% below median its 10-year median of 18.33. Over the past 10 years, this metric has ranged from a low of 4.13 to a high of 24.44. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Life Healthcare Group Holdings' value of 15.87% is 55.4% above this industry median. Based on the distribution chart, Life Healthcare Group Holdings ranks #248 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Life Healthcare Group Holdings has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Life Healthcare Group Holdings' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Life Healthcare Group Holdings ranks #248 out of 668 companies for EBITDA Margin %. This puts Life Healthcare Group Holdings in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Life Healthcare Group Holdings' value of 15.87% is 55.4% above this benchmark. Historically, Life Healthcare Group Holdings' own EBITDA Margin % has ranged from 4.13 to 24.44 over the past decade. While the company's 10-year median is 18.33 vs. the industry median of 10.21, Life Healthcare Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Life Healthcare Group Holdings's current EBITDA Margin % of 15.87% is 55.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Life Healthcare Group Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Life Healthcare Group Holdings's current EBITDA Margin % is 15.87%, which is 13% below median its own 10-year median of 18.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Life Healthcare Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Life Healthcare Group Holdings (JSE:LHC) is currently considered Possible Value Trap. The stock's GF Value™ is R15.61, compared to a current price of R10.43 — trading 33.2% below its estimated fair value. The current EBITDA Margin % is 15.87%, which is 13% below median its 10-year median of 18.33 and 55.4% above the Healthcare Providers & Services industry median of 10.21. Life Healthcare Group Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Life Healthcare Group Holdings (JSE:LHC), the current EBITDA Margin % is 15.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Life Healthcare Group Holdings (JSE:LHC) Overvalued in 2026?
Based on GuruFocus' analysis, Life Healthcare Group Holdings stock appears to be undervalued.
The current stock price of R10.43 is trading 33.2% below its estimated GF Value™ of R15.61.
GuruFocus considers Life Healthcare Group Holdings to be Possible Value Trap.
Key valuation signals for JSE:LHC:
EBITDA Margin %: 15.87% (13% below median its 10-year median of 18.33)
GF Value™: R15.61 vs. price of R10.43 (33.2% below fair value)
Industry Position: 55.4% above the Healthcare Providers & Services median (#248 of 668)
No single metric tells the full story. See the JSE:LHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Life Healthcare Group Holdings Business Description
Life Healthcare Group Holdings Ltd is a private healthcare provider in southern Africa, prominently serving the medically insured market. The company is in the business of providing hospital and complementary services (which include mental healthcare, acute rehabilitation, renal dialysis, oncology and diagnostics) and healthcare services. It operates via three segments: Hospitals segment (acute hospitals), the Complementary Services segment (mental health, acute rehabilitation, renal dialysis, oncology and diagnostics) and the Healthcare Services segment (Life Nkanyisa and Life Health Solutions). The majority of revenue is derived from the hospitals segment. Geographically, the company generates the maximum revenue from Southern Africa.
56GF Score
Get the complete analysis for JSE:LHC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LHC has been successfully added to your 
